Formulation And Development of Lipospheres To Enhance the Solubility and Therapeutic Efficacy of Cefixime

There is a possibility that the inability of cefixime, a cephalosporin of the third generation, to dissolve in water might have an influence on its therapeutic efficacy. The primary focus of the ongoing study is on the development of lipid-based lipospheres that have the potential to enhance the solubility, bioavailability, and controlled release performance of cefixime. When making lipospheres, the melt dispersion method was used. This method included the utilization of a number of different lipids, including cetyl alcohol, cetostearyl alcohol, and stearyl alcohol. For the purpose of stabilization, polyvinyl alcohol (PVA) was used. For the purpose of evaluating the formulations, some of the parameters that were used were in vitro drug release, encapsulation efficiency, drug content, particle size, shape, and percentage yield. According to the results, the particle size ranged from 64.99 ± 1.83 to 98.14 ± 1.52 µm. The formulation that was improved (CFX2) and included cetyl alcohol had the highest encapsulation efficacy, with a 95.50 ± 1.23% success rate. An analysis using a scanning electron microscope revealed that the drug had a little amount of crystallization, and that the particles were distinct, spherical, and had smooth surfaces. In vitro release experiments demonstrated that Cefixime was able to be released in a controlled and sustained manner for a period of sixteen hours. A total medication release of 82.95 ± 0.99% was observed in the formulation that underwent improvement. The findings of the study indicate that lipospheres are an effective vehicle for enhancing the solubility and therapeutic potential of cefixime, which is something that bodes well for the use of lipospheres in the administration of oral medicine.